Solara Active Pharma Sciences Ltd updated on the sale of 100% shareholding in their subsidiary SeQuent Penems Private Limited to M/s. Symbio Generics India Pvt. Ltd for Rs.12.50 crores.
AI Assistant
Solara Active Pharma Sciences Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.